Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis - Wikidata - wikimedia - TriplyDB

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis

http://www.wikidata.org/entity/Q38213707

about

Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside Chitotriosidase in the Pathogenesis of Inflammation, Interstitial Lung Diseases and COPD Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.EFFECT OF TRIPTOLIDE ON PROLIFERATION AND APOPTOSIS OF ANGIOTENSIN II-INDUCED CARDIAC FIBROBLASTS IN VITRO: A PRELIMINARY STUDY Blocking the Wnt/β-Catenin Pathway by Lentivirus-Mediated Short Hairpin RNA Targeting β-Catenin Gene Suppresses Silica-Induced Lung Fibrosis in Mice.Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model.Apolipoprotein A1 Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition of Alveolar Epithelial Cells Metformin Reduces Bleomycin-induced Pulmonary Fibrosis in Mice.Protective effects of ulinastatin and methylprednisolone against radiation-induced lung injury in mice Bach1 siRNA attenuates bleomycin-induced pulmonary fibrosis by modulating oxidative stress in mice.Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.Promising new treatment targets in patients with fibrosing lung disorders.The potential role of IL-33/ST2 signaling in fibrotic diseases.Microencapsulation of Lefty-secreting engineered cells for pulmonary fibrosis therapy in mice.The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis.Autophagy and the Unfolded Protein Response Promote Pro-fibrotic Effects of TGFβ1 in Human Lung Fibroblasts.Dexamethasone reduces serum level of IL-17 in Bleomycin-A5-induced rats model of pulmonary fibrosis.Upregulated miR-29c suppresses silica-induced lung fibrosis through the Wnt/β-catenin pathway in mice.Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.Bacillus Calmette-Guerin alleviates airway inflammation and remodeling by preventing TGF-β1 induced epithelial-mesenchymal transition.

P2860

Q28067306-0E679E98-0809-4748-ABD6-5F195DFF9764 Q28384802-92AB278F-7794-4C4D-95AD-3EC50BA883BB Q33577258-E2DFDBA3-A2A7-4DEC-B6F1-2C89147FA5AC Q33622959-0C9CFFC2-8840-4B0C-AC67-891885066C1C Q36102377-7C706EC0-27B6-47A0-9333-9E4040DCC383 Q36909908-9102FEE0-AD8E-4560-AB11-27393DBD942F Q37092455-76DB6E03-B97A-4817-9007-F962369F4DB5 Q37153201-11695EED-C0DC-40E9-9026-F9DC99AC8C21 Q37301055-C1DEE095-EE02-4FCB-A8A7-72836B3A1448 Q37527828-9272A1DE-D022-47AB-B3AA-1B50798E8FEE Q37636784-ED4CBC39-2F54-4C9B-946D-32EFEF1BDDE1 Q38269057-6C81F6F4-F106-48FA-8229-59DD8C50283B Q38424483-90B6ECED-A9B6-4692-A481-1D931B4BAEDF Q40329746-3BCA08D3-6C24-47F9-91D5-6FDD95AA4F58 Q42694416-9C26F9B0-189C-4D77-82AC-C319302D9EFB Q45970202-EB477A65-E52F-422A-A02D-621DF6E6C08F Q47864519-4DEB3E03-5135-48A1-B397-555E5EC1052C Q50026210-5D52F19D-9BC0-4E93-A7C3-77F38F491BC1 Q53518490-87225B0F-DC64-4BAE-A4B7-AA24E7188536 Q55044241-0686A4C4-6D11-49D9-B63B-4C1BAD90A8D5

P2860

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis

http://www.wikidata.org/entity/Q38213707

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis

@en

type

label

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis

@en

prefLabel

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis

@en

P1433

Q38213707-107E34A4-0FC3-4839-B4A6-D82C4C5999B7

P1476

Q38213707-246D29FF-D624-46EB-9846-8C548FE9E52E

P2093

Q38213707-186E22CE-BA08-4478-A049-F78F0971FDD1

Q38213707-2AC79C67-B3DB-494E-9864-93858516FFF9

Q38213707-594BEB90-41B3-4580-AA91-DC322B3A6D9F

Q38213707-6272EA51-81BA-4A26-8AB0-AF3D316DBCDA

Q38213707-746BED86-4494-480E-996D-C61D847C5AF9

Q38213707-A7757799-1946-4F0C-A1D3-8119DF913772

Q38213707-E4DD85D0-70AA-4F76-8160-EEDA7650529A

Q38213707-E60F9988-03A8-4966-999C-C491A5BC5050

Q38213707-ECE24FE6-DCA0-46B4-A363-0373F69935B0

P275

Q38213707-5956B4F3-D837-437A-919F-D9A58A6C929A

P2860

Q38213707-014CCDD1-D055-4E00-8EC5-27A46D3A1344

Q38213707-02F244FA-E80F-49DA-B938-A69AA6867C22

Q38213707-038C465E-148F-4E81-BC9D-D3095441AD1E

Q38213707-04757BB0-F193-4AE7-BC95-60D58F6C8E94

Q38213707-0687DD6C-9CC9-4AF9-8D3A-BD52573B86BB

Q38213707-093B8818-F0EE-4E1D-AFA9-3A78AE69B7C5

Q38213707-105537D0-FFAB-493F-9B1E-1650D890335F

Q38213707-15BF8A87-6124-41E6-A70E-7824CA5DC798

Q38213707-1B9D64F2-CDD2-48A8-AEB9-41B0C3BE4190

Q38213707-1C48D2E8-C2C4-456B-8F0B-DCB22352EC0C

P304

Q38213707-5794E790-E7EB-41B5-818C-0A6A64F1749D

P31

Q38213707-D563A408-89BF-4D5F-A731-6A772B5F48BB

Q38213707-F93EEAE8-DD4F-4CA1-9BAA-2507429D8944

P356

Q38213707-4AB8AA24-18A5-4842-91CF-DC1EC5411D8D

P433

Q38213707-F09A3321-A52A-4ACE-85ED-670B0270053B

P478

Q38213707-6A816092-E794-45A3-8487-C9D363D0D508

P577

Q38213707-6683185E-7141-4A63-908F-3B6242216564

Q38213707-DE3C07B7-4ADA-4AE5-9647-4EA2966505B9

P5875

Q38213707-BE0C561A-1C3A-4F18-A644-7D52EF925379

P698

Q38213707-758A2CAA-98C5-4496-8486-DB66251E74E1

P921

Q38213707-2050F9F4-C3C0-4F6C-A5EE-AAD899631A83

Q38213707-4CE22F0D-C66E-4DAA-AE30-A70A32BBD24C

Q38213707-E033687F-3F92-4F34-B718-21277886DEB9

P932

Q38213707-226ED707-BE92-4E85-ABCE-2892759B8F9C

P356

KJIM.2014.29.3.281

P1433

The Korean journal of internal medicine

P1476

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis

@en

P2093

Boram Han

http://www.w3.org/2001/XMLSchema#string

Chang-Min Lee

http://www.w3.org/2001/XMLSchema#string

Chun Geun Lee

http://www.w3.org/2001/XMLSchema#string

Jack A Elias

http://www.w3.org/2001/XMLSchema#string

Jeiwook Chae

http://www.w3.org/2001/XMLSchema#string

Jin Wook Park

http://www.w3.org/2001/XMLSchema#string

Pyoung Oh Yoon

http://www.w3.org/2001/XMLSchema#string

Won-Kyung Cho

http://www.w3.org/2001/XMLSchema#string

Yang Zhou

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities

Fibrosis and angiogenesis

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

Smad regulation in TGF-beta signal transduction

Regulation of immune responses by TGF-beta

TGF-beta is a critical mediator of acute lung injury

Reduced tumor necrosis factor-alpha and transforming growth factor-beta1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposure

The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis.

A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin.

P304

281-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3904/KJIM.2014.29.3.281

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262537808

http://www.w3.org/2001/XMLSchema#string

P698

24851060

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

Anagraw amesgunef

P932

4028515

http://www.w3.org/2001/XMLSchema#string